Matthias Lormann

Title: Matthias Lormann: Innovator in Pharmaceutical Chemistry

Introduction

Matthias Lormann is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing complex compounds. His work has led to the granting of multiple patents, showcasing his innovative approach to chemical synthesis.

Latest Patents

Lormann holds 2 patents that focus on the preparation of pharmaceutical compounds. His first patent describes a process for obtaining Cizolirtine and its enantiomers. This process involves the asymmetric addition of a metalated phenyl reagent to a pyrazolcarbaldehyde in the presence of a chiral ligand, resulting in the formation of chiral alcohols. These chiral alcohols are subsequently O-alkylated to yield Cizolirtine or its enantiomers. His second patent outlines a similar process for obtaining enantiomers of thienylazolylalcoxyethanamines. This method also utilizes asymmetric addition, this time with a metalated thienyl reagent, to produce chiral alcohols that are further processed into pharmaceutically active compounds.

Career Highlights

Throughout his career, Matthias Lormann has worked with reputable organizations, including Laboratorios Del Dr. Esteve S.A. His experience in these companies has allowed him to refine his skills in pharmaceutical development and innovation.

Collaborations

Lormann has collaborated with esteemed colleagues such as Antoni Torrens Jover and Helmut Heinrich Buschmann. These partnerships have contributed to his success in the field and have fostered a collaborative environment for innovation.

Conclusion

Matthias Lormann's contributions to pharmaceutical chemistry through his innovative processes and collaborations highlight his role as a significant inventor in the industry. His patents reflect a commitment to advancing the field and improving the synthesis of important pharmaceutical compounds.